[Collection]
CollectionName=Prostate pre-validation for hk2, hk4 and hk11.
CollectionDescription=Data and Marker Performance Summary for three prostate markers hk2, hk4 and hk11.
Discipline=
Institution=Mount Sinai Hospital
InstitutionId=144
LeadPI=Eleftherios Diamandis
LeadPIId=1719
DataCustodian=Azza Eissa
DataCustodianEmail=AEissa@mtsinai.on.ca
Organ=Prostate
OrganId=26
OwnerPrincipal=cn=All Users,dc=edrn,dc=jpl,dc=nasa,dc=gov
CollaborativeGroup=Prostate and Urologic
QAState=Under Review
Consortium=EDRN
ProtocolName=Prostate Rapid Reference Set Application: Eleftherios Diamandis - Mt Sinai (2006)
ProtocolId=287
Species=
MethodDetails=Three markers (hk2, hk4 and hk11) were measured among 123 samples (60 controls, 63 cases). Among the cases, 33 had low Gleason grade (less than 7) and 30 had high Gleason grade (greather than or equal to 7).
ResultsAndConclusionSummary=In evaluating the performance of 163 markers, 3 samples (case) were missing due to QNS. 116 observations had PSA measured. 
PubMedID=http://www.ncbi.nlm.nih.gov/pubmed/N/A
DateDatasetFrozen=N/A
DataDisclaimer=Data and information released from the National Cancer Institute (NCI) are provided on an "AS IS" basis, without warranty of any kind, including without limitation the warranties of merchantability, fitness for a particular purpose and non-infringement. Availability of this data and information does not constitute scientific publication. Data and/or information may contain errors or be incomplete. NCI and its employees make no representation or warranty, express or implied, including without limitation any warranties of merchantability or fitness for a particular purpose or warranties as to the identity or ownership of data or information, the quality, accuracy or completeness of data or information, or that the use of such data or information will not infringe any patent, intellectual property or proprietary rights of any party. NCI shall not be liable for any claim for any loss, harm, illness or other damage or injury arising from access to or use of data or information, including without limitation any direct, indirect, incidental, exemplary, special or consequential damages, even if advised of the possibility of such damages. In accordance with scientific standards, appropriate acknowledgment of NCI should be made in any publications or other disclosures concerning data or information made available by NCI. 
CollectionId=Prostate_pre-validation_for_hk2,_hk4_and_hk11.
Date=2010-03-01T01:13:00.000Z
[Dataset]
DatasetId=Prostate_pre-validation_for_hk2,_hk4_and_hk11.
DatasetName=Prostate pre-validation for hk2, hk4 and hk11.
DatasetDescription=Prostate pre-validation for hk2, hk4 and hk11.
